- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01006993
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator (FASTFlo tPA)
March 10, 2010 updated by: CoAxia
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving tPA
To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic stroke patients following administration of intravenous tPA.
Study Overview
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ischemic stroke
- NIHSS between 5-22
- Persistent clinical deficits following administration of rt-PA
Exclusion Criteria:
- Planned thrombectomy
- Aortic pathology
- Severe heart disease
- Other conditions the doctor will assess
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NeuroFlo Treatment
|
NeuroFlo™ catheter 45 minute treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
An assessment of serious adverse events occurring in ischemic stroke patients undergoing NeuroFlo treatment.
Time Frame: Baseline to 30 days post-treatment
|
Baseline to 30 days post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Potential patient benefit will be assessed through collection of neurological indices.
Time Frame: Baseline through 90 days
|
Baseline through 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: FASTFlo Steering Committee, Various
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (Actual)
July 1, 2009
Study Completion (Actual)
January 1, 2010
Study Registration Dates
First Submitted
November 2, 2009
First Submitted That Met QC Criteria
November 2, 2009
First Posted (Estimate)
November 3, 2009
Study Record Updates
Last Update Posted (Estimate)
March 11, 2010
Last Update Submitted That Met QC Criteria
March 10, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CD-0258
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on NeuroFlo catheter
-
CoAxiaCompletedCerebrovascular AccidentUnited States, Canada, Switzerland, Germany
-
CoAxiaCompletedCerebrovascular AccidentUnited States, Spain, Canada, Puerto Rico, Israel, Germany, Belgium, Switzerland, Austria, Hungary
-
University of California, Los AngelesCoAxiaWithdrawnAcute StrokeUnited States
-
University of British ColumbiaCompletedIschemia | Chronic Pain | Phantom Limb Pain | Vascular DiseaseCanada
-
ReFlow Medical, Inc.Not yet recruitingCoronary OcclusionUnited States
-
University College Hospital GalwayCompleted
-
Coloplast A/SCompletedIntermittent Urethral CatheterizationDenmark
-
Coloplast A/SCompletedSpinal Cord InjuryDenmark
-
University Hospital, Basel, SwitzerlandBoston Scientific CorporationCompleted
-
Anhui Provincial HospitalCompletedBiliary CalculiChina